Orlistat 是一种通用的脂肪酶抑制剂,对人类十二指肠液中的 PL 的 IC50 为 122 ng/ml。Orlistat 还是脂肪酸合成酶(FASN)的抑制剂,可用于长期研究肥胖症的口服药物。具有抗动脉粥样硬化效果。
顾客使用 Adooq 产品发表的高质量科研文献
Adooq用户使用Orlistat发表的1篇文献
生物活性
Discription | Orlistat is a general lipase inhibitor with IC50 of 122 ng/ml for PL from human duodenal juice. Orlistat is also an inhibitor of fatty acid synthase (FASN), is used orally for long-term research of obesity. Anti-atherosclerotic effect. |
|||||
---|---|---|---|---|---|---|
Cell Research |
|
产品信息
目录号 | A10676 |
---|---|
分子式 | C29H53NO5 |
分子量 | 495.73 |
CAS号 | 96829-58-2 |
SMILES | CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O |
其他名称 | Tetrahydrolipstatin |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
溶解性数据
In vitro (25°C) | DMSO | 97 mg/mL (195.67 mM) | |
Water | Insoluble | ||
Ethanol | 97 mg/mL (195.67 mM) | ||
In vivo | 5% DMSO+40% PEG 300+5% Tween 80+ddH2O | 12 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Preparing Stock Solutions
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.17 mL | 100.86 mL | 201.72 mL |
0.5 mM | 4.03 mL | 20.17 mL | 40.34 mL |
1 mM | 2.02 mL | 10.09 mL | 20.17 mL |
5 mM | 0.4 mL | 2.02 mL | 4.03 mL |
Useful Calculator
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
Keywords: 购买 Orlistat | Orlistat 供应商 | Orlistat 花费 | Orlistat 生产商 | 订购 Orlistat | Orlistat 代理商
| 购买 96829-58-2 | 96829-58-2 供应商 | 96829-58-2 花费 | 96829-58-2 生产商 | 订购 96829-58-2 | 96829-58-2 代理商